Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of cjc 1295 injection in China. Welcome to wholesale bulk high quality cjc 1295 injection for sale here from our factory. Good service and reasonable price are available.
CJC 1295 Injection is an artificially synthesized growth hormone-releasing hormone (GHRH) analogue and belongs to peptide hormones. Its CAS number is 863288-34-0, its molecular formula is C152H252N44O42, and its molecular weight is approximately 3367.954. CJC 1295 is composed of 30 kinds of amino acids. By simulating the active segment of natural GHRH, it stimulates the anterior pituitary cells to release growth hormone (GH), thereby promoting the increase of IGF-1 (insulin-like growth factor-1) level in the body. With the in-depth research on this injection, its application prospects in fields such as anti-aging, muscle repair and immune regulation will be even broader.
|
|
|
|
Customized Bottle Caps And Corks:
|
|
CJC1295 COA
 |
||
| Certificate of Analysis | ||
| Compound name | CJC1295 | |
| Grade | Pharmaceutical grade | |
| CAS No. | 863288-34-0 | |
| Quantity | 40g | |
| Packaging standard | PE bag+Al foil bag | |
| Manufacturer | Shaanxi BLOOM TECH Co., Ltd | |
| Lot No. | 202512090051 | |
| MFG | Dec 9th 2025 | |
| EXP | Dec 8th 2028 | |
| Structure |
|
|
| Item | Enterprise standard | Analysis result |
| Appearance | White or almost white powder | Conformed |
| Water content | ≤5.0% | 0.85% |
| Loss on drying | ≤1.0% | 0.32% |
| Heavy Metals | Pb≤0.5ppm | N.D. |
| As≤0.5ppm | N.D. | |
| Hg≤0.5ppm | N.D. | |
| Cd≤0.5ppm | N.D. | |
| Purity (HPLC) | ≥99.0% | 99.80% |
| Single impurity | <0.8% | 0.42% |
| Total microbial count | ≤750cfu/g | 96 |
| E. Coli | ≤2MPN/g | N.D. |
| Salmonella | N.D. | N.D. |
| Ethanol (by GC) | ≤5000ppm | 565ppm |
| Storage | Store in a sealed, dark, and dry place below -20°C | |
|
|
||
Treatment of Growth Hormone Deficiency
CJC 1295 Injection prolongs the half-life of growth hormone-releasing hormone (GHRH) to continuously stimulate the pituitary gland to secrete growth hormone (GH), effectively elevating plasma GH and insulin-like growth factor-1 (IGF-1) levels. For childhood or adult growth hormone deficiency caused by pituitary insufficiency, CJC-1295 can replace traditional short-acting GHRH analogs, reducing the frequency of injections and improving treatment compliance.
Adjuvant Treatment of Lipodystrophy
Patients with lipodystrophy often experience GH resistance or insufficient secretion due to abnormal adipose tissue metabolism. CJC-1295 may help alleviate related symptoms by promoting GH secretion and improving fat metabolism.
Other Potential Medical Applications
Research is underway to explore the application of CJC-1295 in enhancing immune function, increasing bone mineral density, and promoting cellular repair (e.g., of the skin and organs), though a broad clinical consensus on these uses has not yet been established.
This product is an artificially synthesized growth hormone-releasing hormone (GHRH) analogue. By simulating the active regions of natural GHRH, the anterior pituitary cells are stimulated to release growth hormone (GH), thereby promoting the increase of IGF-1 (insulin-like growth factor-1) levels in the body. The following will introduce its analytical methods from five aspects: chemical property analysis, biological activity detection, purity and impurity analysis, stability study and safety evaluation.
Chemical Property Analysis
Molecular Structure and Molecular Weight determination
The molecular structure and molecular weight of CJC 1295 can be accurately determined through mass spectrometry (MS) and nuclear magnetic resonance (NMR) techniques. Mass spectrometry analysis confirms the molecular composition by ionizing the sample and measuring the mass-to-charge ratio of the ions. NMR, on the other hand, analyzes the details of molecular structure by detecting the resonance signals of atomic nuclei in a magnetic field.
Solubility test
The solubility of CJC 1295 in water needs to be verified through experiments. Spectrophotometry is usually adopted. The absorbance of the solution is measured at a specific wavelength, and the solubility is calculated in combination with the standard curve. In addition, its dissolution phenomenon in different solvents can also be observed to evaluate its physical stability.
Biological Activity Detection
In vitro cell experiments
The secretion of GH after stimulation with CJC 1295 was detected by enzyme-linked immunosorbent assay (ELISA) using anterior pituitary cells or related cell lines. The experiment requires the setting of blank controls and positive controls to quantify the biological activity of CJC 1295.
In vivo animal experiments
The effects of CJC 1295 on the levels of GH and IGF-1 were evaluated through mouse or rat models. The experiment requires setting up different dose groups and control groups. Blood samples should be collected regularly. Changes in hormone levels should be detected by ELISA or radioimmunoassay (RIA), and physiological indicators such as animal growth and metabolism should be observed.
Purity and Impurity Analysis
High Performance liquid Chromatography (HPLC) analysis
HPLC is the main method for detecting the purity of CJC 1295 Injection. By choosing the appropriate chromatographic column and mobile phase, the components in the sample are separated and quantified using a UV detector or a fluorescence detector. By comparing the peak area of the sample with that of the standard, the purity is calculated and possible impurity peaks are identified.
Mass Spectrometry (LC-MS)
LC-MS combines the separation ability of HPLC with the identification ability of mass spectrometry, and can detect impurities in CJC 1295 more accurately. Impurities can be identified and quantified through full scanning or by selecting the ion monitoring mode, and their potential impact on product quality can be evaluated.
Stability Research
Accelerated stability test
The CJC 1295 sample was placed under high temperature, high humidity or light conditions, and its purity, biological activity and appearance changes were detected regularly. By comparing the test results at different time points, the stability of the product is evaluated and the validity period is determined.
Long-term stability test
Under the recommended storage conditions, long-term tracking tests were conducted on the CJC 1295 sample. By regularly testing indicators such as purity and biological activity, the stability of the product under normal storage conditions is evaluated, providing a scientific basis for the product's shelf life.
Safety Assessment
Acute Toxicity test
The acute toxicity of CJC 1295 to experimental animals was evaluated through single or multiple administration methods. Observe the behavior, weight changes and death of the animals to determine the maximum tolerated dose (MTD) or median lethal dose (LD50).
Long-term toxicity test
Over a relatively long period of time, different doses of CJC 1295 were administered to the experimental animals to observe its effects on the growth, metabolism, reproduction and immune system of the animals. The long-term safety of the product was evaluated through hematological, biochemical and pathological examinations.
Local irritation test
At the animal skin or intramuscular injection site, observe the local reactions caused by CJC 1295, such as redness, swelling, inflammation, etc. Through histological examination, the local irritation of the product was evaluated to provide a safety reference for clinical medication.
Conclusion
The analytical methods of CJC 1295 Injection involve multiple aspects such as chemical properties, biological activity, purity and impurities, stability and safety. By comprehensively applying technical means such as mass spectrometry analysis, HPLC, ELISA, and animal experiments, the quality and safety of CJC 1295 can be comprehensively evaluated, providing a scientific basis for its clinical application. In the future, with the continuous development of analytical technology, the analytical method of CJC 1295 will be more accurate and efficient, providing strong support for drug research and development and quality control.
Correlation with BMI>30
This injection is an artificially synthesized growth hormone-releasing hormone (GHRH) analogue.By simulating the effect of natural GHRH, it stimulates the anterior pituitary cells to release growth hormone (GH), thereby promoting the increase of insulin-like growth factor-1 (IGF-1) levels in the body. For people with a BMI>30, this injection may have certain potential application value, but there are also some issues that need attention.
Potential Benefits for People with BMI>30
Promote muscle growth and reduce fat
People with a BMI>30 usually have a higher body fat percentage. This injection solution can promote protein synthesis and fat breakdown, and improve the body's composition. It helps reduce body fat and increase muscle mass by promoting the proliferation and differentiation of muscle cells and inhibiting the growth of fat cells. For this group of people, it helps to improve the decline in physical functions caused by obesity, ensure the basal metabolic rate, and reduce fat accumulation due to aging or obesity.
Improve metabolism-related indicators
Obese people often have metabolic disorders, such as abnormal blood sugar and blood lipids. This product can regulate blood sugar levels to a certain extent and help improve the overall metabolic state.By promoting the secretion of growth hormone, it may have a positive impact on insulin sensitivity, thereby playing a certain auxiliary role in blood sugar control.
Strengthen the immune system and promote tissue repair
Obesity may affect the function of the immune system, reducing the body's resistance to pathogens. The product can optimize the immune system function and enhance the immunity of the body. In addition, it also helps with the wound healing, cartilage repair and other tissue repair processes, and is of certain assistance to the recovery of injuries that may occur in people with a BMI>30 during exercise or other activities.
Potential Risks
Adverse reaction
Some adverse reactions may occur during the use of this injection, such as reactions at the injection site (irritation, erythema, induration, pain, itching, etc.), systemic reactions (headache, diarrhea, vasodilation, nausea, abdominal pain, etc.), water retention, nerve compression pain (such as wrist pain), etc.People with a BMI over 30 May have some underlying diseases or a decline in physical functions, and these adverse reactions may have a greater impact on them.
The long-term risks are not clear
At present, the long-term usage risks of CJC 1295 Injection are not completely clear. Long-term use may lead to a reduction in the amplitude of GH pulses, decrease the stimulation of GH to tissues, and may also cause a temporary decline in pituitary function. For people with a BMI over 30, due to the particularity of their physical conditions, long-term use may bring more potential risks.
Usage Suggestions
Professional doctor's guidance
People with BMI>30 must consult the opinion of a professional doctor before using it. Doctors will conduct a comprehensive assessment based on an individual's physical condition, health history, drug allergies, etc., to determine whether the drug is suitable for use, as well as the appropriate dosage and frequency of use.
Monitoring and Adjustment
During the usage process, regular physical examinations and monitoring are required, including the detection of indicators such as blood sugar, blood lipid, and hormone levels. Based on the monitoring results, doctors can adjust the medication plan in a timely manner to ensure the safety and effectiveness of the drugs.
Combine lifestyle intervention
This product cannot replace a healthy lifestyle. People with a BMI over 30 should combine medication with a reasonable diet and appropriate exercise to achieve better weight loss and health improvement.
FAQ
What are the benefits of CJC-1295 injection?
+
-
Benefits of CJC-1295 Injections
Key metabolic benefits include: Accelerated Fat Loss: Increases metabolic rate to help burn stubborn body fat. Lean Muscle Preservation: Protects muscle mass even while in a caloric deficit. Deep Sleep: Promotes restorative, deep-wave sleep cycles essential for mental clarity.
How much CJC-1295 should I take?
+
-
Dosage and Administration:
Typical dosage: 100-300 micrograms (mcg) of CJC-1295/Ipamorelin per day in single or divided doses. Injections are administered subcutaneously (under the skin), usually once daily. Best administered on an empty stomach in the morning or before bedtime.
How long does it take to see results from a CJC-1295?
+
-
When will I start noticing results from CJC-1295 and ipamorelin? Many patients notice improvements in sleep and energy within the first few weeks, with continued benefits developing over several months.
Hot Tags: cjc 1295 injection, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale